Contents
Current Cancer Drug Targets, Volume 9 - Number 6
Molecular Features, Markers, Drug Targets, and Prospective Targeted Therapeutics in Cardiac Myxoma
, 9(6): 705 - 716Debmalya Barh, Anil Kumar, Suvro Chatterjee and Triantafillos Liloglou
DOI: 10.2174/156800909789271549
Caspase-Independent Pathways of Programmed Cell Death: The Unraveling of New Targets of Cancer Therapy?
, 9(6): 717 - 728C. Constantinou, K. A. Papas and A. I. Constantinou
DOI: 10.2174/156800909789271512
Sunitinib (SUTENT, SU11248) Suppresses Tumor Growth and Induces Apoptosis in Xenograft Models of Human Hepatocellular Carcinoma
, 9(6): 738 - 747H. Huynh, V. C. Ngo, S. P. Choo, D. Poon, H. N. Koong, C. H. Thng, H. C. Toh, L. Zheng, L. C. Ong, Y. Jin, I. C. Song, A. P.C. Chang, H. S. Ong, A. Y.F. Chung, P. K.H. Chow and K. C. Soo
DOI: 10.2174/156800909789271530
Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy
, 9(6): 748 - 760J. van der Veeken, S. Oliveira, R. M. Schiffelers, G. Storm, P.M.P. van Bergen en Henegouwen and R. C. Roovers
DOI: 10.2174/156800909789271495
Heat Shock Protein 90 – a Potential Target in the Treatment of Human Acute Myelogenous Leukemia
, 9(6): 761 - 776H. Reikvam, E. Ersvær and O. Bruserud
DOI: 10.2174/156800909789271486
Increased Tumor Oxygenation and Drug Uptake During Anti-Angiogenic Weekly Low Dose Cyclophosphamide Enhances the Anti-Tumor Effect of Weekly Tirapazamine (Supplementry Material)
, 9(6): 777 - 788J. C. Doloff, N. Khan, J. Ma, E. Demidenko, H. M. Swartz and Y. Jounaidi
DOI: 10.2174/156800909789271503
Webmaster Contact: info@benthamscience.org